GB0314049D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number: GB0314049D0
Authority: GB; United Kingdom
Prior art keywords: therapeutic agents; therapeutic; agents
Prior art date: 2003-06-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0314049.8A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

AstraZeneca AB

Original Assignee

AstraZeneca AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-18

Filing date

2003-06-18

Publication date

2003-07-23

2003-06-18 Application filed by AstraZeneca AB filed Critical AstraZeneca AB

2003-06-18 Priority to GBGB0314049.8A priority Critical patent/GB0314049D0/en

2003-07-23 Publication of GB0314049D0 publication Critical patent/GB0314049D0/en

2004-06-16 Priority to PCT/SE2004/000967 priority patent/WO2004111038A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Immunology (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Child & Adolescent Psychology (AREA)
Hematology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GBGB0314049.8A 2003-06-18 2003-06-18 Therapeutic agents Ceased GB0314049D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB0314049.8A GB0314049D0 (en)	2003-06-18	2003-06-18	Therapeutic agents
PCT/SE2004/000967 WO2004111038A1 (en)	2003-06-18	2004-06-16	5,6-bis (4-chlorophenyl)-n-piperidin1-yl-3-(piperidin-1-yl-carbonyl)pyrazine-2-carboxamide

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0314049.8A GB0314049D0 (en)	2003-06-18	2003-06-18	Therapeutic agents

Publications (1)

Publication Number	Publication Date
GB0314049D0 true GB0314049D0 (en)	2003-07-23

Family

ID=27636731

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0314049.8A Ceased GB0314049D0 (en)	2003-06-18	2003-06-18	Therapeutic agents

Country Status (2)

Country	Link
GB (1)	GB0314049D0 (en)
WO (1)	WO2004111038A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1546115A4 (en)	2002-09-27	2010-08-04	Merck Sharp & Dohme	SUBSTITUTED PYRIMIDINES
WO2006088814A2 (en) *	2005-02-15	2006-08-24	Jazz Pharmaceuticals	Dosage form and method for sustained release of a substituted pyrazine compound
WO2006106054A1 (en)	2005-04-06	2006-10-12	F. Hoffmann-La Roche Ag	Pyridine-3-carboxamide derivatives as cb1 inverse agonists
US7629346B2 (en)	2006-06-19	2009-12-08	Hoffmann-La Roche Inc.	Pyrazinecarboxamide derivatives as CB1 antagonists
US7781593B2 (en)	2006-09-14	2010-08-24	Hoffmann-La Roche Inc.	5-phenyl-nicotinamide derivatives
EP2025674A1 (en)	2007-08-15	2009-02-18	sanofi-aventis	Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
EP2348857B1 (en)	2008-10-22	2016-02-24	Merck Sharp & Dohme Corp.	Novel cyclic benzimidazole derivatives useful anti-diabetic agents
AU2009309037A1 (en)	2008-10-31	2010-05-06	Merck Sharp & Dohme Corp.	Novel cyclic benzimidazole derivatives useful anti-diabetic agents
JP2013520502A (en)	2010-02-25	2013-06-06	メルク・シャープ・エンド・ドーム・コーポレイション	Novel cyclic benzimidazole derivatives that are useful anti-diabetic drugs
US8410107B2 (en)	2010-10-15	2013-04-02	Hoffmann-La Roche Inc.	N-pyridin-3-yl or N-pyrazin-2-yl carboxamides
US8669254B2 (en)	2010-12-15	2014-03-11	Hoffman-La Roche Inc.	Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents
JP5728099B2 (en)	2011-02-25	2015-06-03	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	Novel cyclic azabenzimidazole derivatives useful as antidiabetic agents
RU2015106909A (en)	2012-08-02	2016-09-27	Мерк Шарп И Доум Корп.	ANTI-DIABETIC TRICYCLIC COMPOUNDS
WO2014130608A1 (en)	2013-02-22	2014-08-28	Merck Sharp & Dohme Corp.	Antidiabetic bicyclic compounds
EP2970119B1 (en)	2013-03-14	2021-11-03	Merck Sharp & Dohme Corp.	Novel indole derivatives useful as anti-diabetic agents
WO2015051496A1 (en)	2013-10-08	2015-04-16	Merck Sharp & Dohme Corp.	Antidiabetic tricyclic compounds
EP3551176A4 (en)	2016-12-06	2020-06-24	Merck Sharp & Dohme Corp.	ANTIDIABETIC HETEROCYCLIC COMPOUNDS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH06501926A (en) *	1990-08-06	1994-03-03	藤沢薬品工業株式会社	heterocyclic compound
FR2713225B1 (en) *	1993-12-02	1996-03-01	Sanofi Sa	Substituted N-piperidino-3-pyrazolecarboxamide.
CN1205188C (en) *	2000-03-23	2005-06-08	索尔瓦药物有限公司	4,5-dihydro-1h-pyrazole derivatives having cbi-antagonistic activity
SE0104332D0 (en) *	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents
SE0104330D0 (en) *	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents

2003
- 2003-06-18 GB GBGB0314049.8A patent/GB0314049D0/en not_active Ceased
2004
- 2004-06-16 WO PCT/SE2004/000967 patent/WO2004111038A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2004111038A1 (en)	2004-12-23

Publication	Publication Date	Title
GB0303910D0 (en)	2003-03-26	Therapeutic agents
GB0308318D0 (en)	2003-05-14	Therapeutic agents
GB0314079D0 (en)	2003-07-23	Therapeutic agents
GB0314057D0 (en)	2003-07-23	Therapeutic agents
GB0313250D0 (en)	2003-07-16	Therapeutic agents
GB0314261D0 (en)	2003-07-23	Therapeutic agents
GB0316237D0 (en)	2003-08-13	Therapeutic agents
GB0316232D0 (en)	2003-08-13	Therapeutic agents
GB0314049D0 (en)	2003-07-23	Therapeutic agents
GB0314129D0 (en)	2003-07-23	Therapeutic agents
GB0311859D0 (en)	2003-06-25	Therapeutic agents
GB0311201D0 (en)	2003-06-18	Therapeutic agents
GB0301350D0 (en)	2003-02-19	Therapeutic agents
GB0314136D0 (en)	2003-07-23	Therapeutic agents
GB0314130D0 (en)	2003-07-23	Therapeutic agents
GB0314260D0 (en)	2003-07-23	Therapeutic agents
GB0314134D0 (en)	2003-07-23	Therapeutic agents
GB0314075D0 (en)	2003-07-23	Therapeutic agents
GB0304524D0 (en)	2003-04-02	Therapeutic agents
GB0314131D0 (en)	2003-07-23	Therapeutic agents
GB0314078D0 (en)	2003-07-23	Therapeutic agents
GB0308759D0 (en)	2003-05-21	Therapeutic agents
GB0305823D0 (en)	2003-04-16	Therapeutic agents
GB0305279D0 (en)	2003-04-09	Therapeutic agents
GB0305281D0 (en)	2003-04-09	Therapeutic agents

Legal Events

Date	Code	Title	Description
2005-01-26	AT	Applications terminated before publication under section 16(1)